- United States
- /
- Medical Equipment
- /
- NasdaqCM:UFPT
Do UFPT’s Year-to-Date Profit Gains Reveal a Durable Shift in Its Growth Trajectory?
Reviewed by Sasha Jovanovic
- UFP Technologies reported its third quarter and nine-month earnings for 2025, with third quarter sales of US$154.56 million and net income of US$16.38 million, alongside year-to-date sales and profit growth compared to the prior year.
- An interesting point is that despite flat third quarter net income, the company delivered strong year-to-date results, highlighting continued improvement in both overall revenue and profitability for 2025.
- We'll examine how UFP Technologies' robust year-to-date sales and profit gains shape its ongoing investment narrative and future outlook.
Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
UFP Technologies Investment Narrative Recap
To be a shareholder in UFP Technologies, you generally need to believe in the company’s ability to capitalize on secular growth in medical device and packaging solutions, maintain customer relationships with leaders like Intuitive Surgical and Stryker, and efficiently integrate acquisitions. The most recent earnings confirm robust year-to-date growth but show flat net income for Q3, which does not materially change the story: gross margin recovery and operational or customer-related risks remain close to the top of the investment case right now.
Among recent announcements, the company’s strong Q3 and year-to-date sales results are center stage. This sales momentum is particularly relevant after the operational hiccups at the AJR facility earlier in the year, supporting confidence that short-term catalysts like margin stabilization and efficiency gains may play out, though recurring operational challenges could still present risks for future performance.
However, investors should also be aware that heavy reliance on a small set of major customers could become a deciding factor if contract dynamics shift or customer strategies change...
Read the full narrative on UFP Technologies (it's free!)
UFP Technologies' narrative projects $694.3 million revenue and $96.3 million earnings by 2028. This requires 5.7% yearly revenue growth and a $29.2 million earnings increase from $67.1 million today.
Uncover how UFP Technologies' forecasts yield a $329.50 fair value, a 34% upside to its current price.
Exploring Other Perspectives
Three individual fair value assessments from the Simply Wall St Community place UFP Technologies between US$329.50 and US$524.77 per share, reflecting a broad spectrum of investor views. While community sentiment suggests possible undervaluation, it’s important to remember recent Q3 numbers highlight that operational efficiency and customer concentration risks continue to shape performance outlooks, consider reading how others weigh these factors.
Explore 3 other fair value estimates on UFP Technologies - why the stock might be worth just $329.50!
Build Your Own UFP Technologies Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your UFP Technologies research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
- Our free UFP Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate UFP Technologies' overall financial health at a glance.
Seeking Other Investments?
Every day counts. These free picks are already gaining attention. See them before the crowd does:
- The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
- These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
- Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 37 best rare earth metal stocks of the very few that mine this essential strategic resource.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqCM:UFPT
UFP Technologies
Designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States.
Excellent balance sheet with acceptable track record.
Market Insights
Community Narratives

